UNLABELLED: Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality of hepatic surgery and during liver transplantation. Previous studies implicated extracellular adenosine signaling in liver protection. Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia. During orthotopic liver transplantation in humans, we observed higher expressional levels of ENT1 than ENT2, in conjunction with repression of ENT1 and ENT2 transcript and protein levels following warm ischemia and reperfusion. Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion. Studies in gene-targeted mice for Ent1 or Ent2 demonstrated selective protection from liver injury in Ent1(-/-) mice. Treatment with selective adenosine receptor antagonists indicated a contribution of Adora2b receptor signaling in ENT-dependent liver protection. CONCLUSION: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury.
UNLABELLED: Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality of hepatic surgery and during liver transplantation. Previous studies implicated extracellular adenosine signaling in liver protection. Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia. During orthotopic liver transplantation in humans, we observed higher expressional levels of ENT1 than ENT2, in conjunction with repression of ENT1 and ENT2 transcript and protein levels following warm ischemia and reperfusion. Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion. Studies in gene-targeted mice for Ent1 or Ent2 demonstrated selective protection from liver injury in Ent1(-/-) mice. Treatment with selective adenosine receptor antagonists indicated a contribution of Adora2b receptor signaling in ENT-dependent liver protection. CONCLUSION: These findings implicate ENT1 in liver protection from ischemia and reperfusion injury and suggest ENT inhibitors may be of benefit in the prevention or treatment of ischemic liver injury.
Authors: Michaela Löffler; Julio C Morote-Garcia; Shelley A Eltzschig; Imogen R Coe; Holger K Eltzschig Journal: Arterioscler Thromb Vasc Biol Date: 2007-03-01 Impact factor: 8.311
Authors: Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid Journal: J Clin Invest Date: 2006-07 Impact factor: 14.808
Authors: Robert D Lasley; Gentian Kristo; Byron J Keith; Robert M Mentzer Journal: Am J Physiol Heart Circ Physiol Date: 2006-09-15 Impact factor: 4.733
Authors: Tobias Eckle; Thomas Krahn; Almut Grenz; David Köhler; Michel Mittelbronn; Catherine Ledent; Marlene A Jacobson; Hartmut Osswald; Linda F Thompson; Klaus Unertl; Holger K Eltzschig Journal: Circulation Date: 2007-03-12 Impact factor: 29.690
Authors: Tobias Eckle; Lars Füllbier; Manfred Wehrmann; Joseph Khoury; Michel Mittelbronn; Juan Ibla; Peter Rosenberger; Holger K Eltzschig Journal: J Immunol Date: 2007-06-15 Impact factor: 5.422
Authors: Fayong Luo; Ngoc-Bao Le; Tingting Mills; Ning-Yuan Chen; Harry Karmouty-Quintana; Jose G Molina; Jonathan Davies; Kemly Philip; Kelly A Volcik; Hong Liu; Yang Xia; Holger K Eltzschig; Michael R Blackburn Journal: FASEB J Date: 2015-11-02 Impact factor: 5.191
Authors: Jonathan Davies; Harry Karmouty-Quintana; Thuy T Le; Ning-Yuan Chen; Tingting Weng; Fayong Luo; Jose Molina; Bhagavatula Moorthy; Michael R Blackburn Journal: Physiol Rep Date: 2014-09-28
Authors: Tobias Eckle; Kelley Brodsky; Megan Bonney; Thomas Packard; Jun Han; Christoph H Borchers; Thomas J Mariani; Douglas J Kominsky; Michel Mittelbronn; Holger K Eltzschig Journal: PLoS Biol Date: 2013-09-24 Impact factor: 8.029